Literature DB >> 11518074

A study of the antidepressant activity of Hypericum perforatum on animal models.

C Gambarana1, P L Tolu, F Masi, M Rinaldi, D Giachetti, P Morazzoni, M G De Montis.   

Abstract

The treatment of non-selected depressed patients with a hydro-alcoholic extract of Hypericum perforatum has been reported to have an efficacy similar to that of classical antidepressants. The effects of H. perforatum on three animal depression models have been studied: (a) an acute form of escape deficit (ED) induced by unavoidable stress; (b) a chronic model of ED, which can be maintained by the administration of mild stressors on alternate days; (c) a model of anhedonia based on the finding that repeated stressors prevent the development of appetitive behavior induced by vanilla sugar in satiated rats fed ad libitum. H. perforatum: (i) acutely protects animals from the sequelae of unavoidable stress; (ii) reverts the chronic escape deficit state maintained by repeated stressors and (iii) preserves the animal's capacity to acquire motivated appetitive behavior. Exposure to chronic stress not only induces escape deficit, but also decreases extraneuronal levels of dopamine in the nucleus accumbens shell; both behavioral and neurochemical effects are reverted by long-term treatment with antidepressants. Three-week treatment with H. perforatum reverted the chronic stress effect on extraneuronal dopamine in the nucleus accumbens. A consistent body of data in the literature suggests that, among the components of H. perforatum extract, hyperforin is the compound (or one of the compounds) responsible for the antidepressant activity. We compared the efficacy of the total extract with the efficacy of hyperforin after p.o. administration. In the acute-escape deficit model, hyperforin showed a potency of about ten times that of the total extract in protecting rats from the sequelae of unavoidable stress. Thus, hyperforin appears to be the most likely active component responsible for the antidepressant activity of H. perforatum.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11518074     DOI: 10.1055/s-2001-15515

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  7 in total

Review 1.  Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients.

Authors:  Mario Wurglics; Manfred Schubert-Zsilavecz
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 2.  St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?

Authors:  Gita Kholghi; Shirin Arjmandi-Rad; Mohammad-Reza Zarrindast; Salar Vaseghi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-03-16       Impact factor: 3.000

Review 3.  Mechanism of action of St John's wort in depression : what is known?

Authors:  Veronika Butterweck
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

4.  Effect of Hypericum perforatum Extract in an Experimental Model of Binge Eating in Female Rats.

Authors:  Maria Vittoria Micioni Di Bonaventura; Giovanni Vitale; Maurizio Massi; Carlo Cifani
Journal:  J Obes       Date:  2012-09-10

5.  An Ethnobotanical Study of Medicinal Plants in the Greek Islands of North Aegean Region.

Authors:  Evangelos Axiotis; Maria Halabalaki; Leandros A Skaltsounis
Journal:  Front Pharmacol       Date:  2018-05-23       Impact factor: 5.810

6.  Antimicrobial Activity and Synergy Investigation of Hypericum scabrum Essential Oil with Antifungal Drugs.

Authors:  Layal Fahed; Marc El Beyrouthy; Naïm Ouaini; Véronique Eparvier; Didier Stien; Sara Vitalini; Marcello Iriti
Journal:  Molecules       Date:  2021-10-29       Impact factor: 4.411

7.  Herbal triplet in treatment of nervous agitation in children.

Authors:  Inga Trompetter; Bianka Krick; Gabriele Weiss
Journal:  Wien Med Wochenschr       Date:  2012-11-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.